Pricing
  1. US-listed companies
  2. SOLENO THERAPEUTICS INC
  3. Financials
  4. Operating income

SOLENO THERAPEUTICS INC (SLNO)

Market cap
$1.9B
P/E ratio
SummaryFinancials
Period EndOperating income (Million USD)YoY (%)
Dec 31, 2024-188+353.49%
Dec 31, 2023-41+69.63%
Dec 31, 2022-24-22.62%
Dec 31, 2021-32-13.12%
Dec 31, 2020-36+54.51%
Dec 31, 2019-23+64.23%
Dec 31, 2018-14+17.50%
Dec 31, 2017-12-10.57%
Dec 31, 2016-14+11.93%
Dec 31, 2015-12+135.67%
Dec 31, 2014-5

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat